Skip to main content
Top
Published in: Clinical Rheumatology 5/2013

01-05-2013 | Original Article

Predictors of medication non-adherence for vasculitis patients

Authors: Delesha M. Carpenter, Susan L. Hogan, Robert F. DeVellis

Published in: Clinical Rheumatology | Issue 5/2013

Login to get access

Abstract

The primary purpose of this article is to document whether demographic, clinical, regimen-related, intrapersonal, and interpersonal factors predict medication non-adherence for vasculitis patients. A secondary purpose is to explore whether adherence varies by medication type and whether patients experienced drug-related side effects. Vasculitis patients (n = 228) completed online baseline and 3-month follow-up surveys. Demographic (age, gender, education, race, marital status, and insurance status), clinical (perceived vasculitis severity, disease duration, vasculitis type, and relapse/remission status), regimen-related (experience of side effects), intrapersonal (depressive symptoms), and interpersonal (adherence-related support from family and friends) factors were measured at baseline. Medication non-adherence was assessed at follow-up using the Vasculitis Self-Management Survey medication adherence subscale (α = 0.89). Variables that significantly correlated (p < 0.05) with non-adherence were included in a linear regression model to predict non-adherence. Younger age (r = −0.23, p < 0.001), female sex (r = 0.16, p < 0.05), experience of side effects (r = 0.15, p < 0.05), and more depressive symptoms (r = 0.22, p < 0.001) were associated with more medication non-adherence. In the regression model, younger age (β = −0.01, p = 0.01) and more depressive symptoms (β = 0.01 p = 0.02) predicted worse adherence. For six out of eight vasculitis medication types, patients who experienced side effects were less adherent than patients who did not experience side effects. Multiple factors are associated with medication non-adherence for vasculitis patients. Providers should discuss medication adherence and drug-related side effects with vasculitis patients. Providers may want to particularly target younger patients and patients with clinical signs of depression.
Literature
1.
go back to reference DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40(9):794–811PubMedCrossRef DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40(9):794–811PubMedCrossRef
2.
go back to reference Haynes RB, Sackett DL (1976) A critical review of "determinants" of patient compliance with therapeutic regimens. In: Compliance with therapeutic regimens. Johns Hopkins University Press, Baltimore, pp 26–39 Haynes RB, Sackett DL (1976) A critical review of "determinants" of patient compliance with therapeutic regimens. In: Compliance with therapeutic regimens. Johns Hopkins University Press, Baltimore, pp 26–39
3.
go back to reference DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–7PubMedCrossRef DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–7PubMedCrossRef
4.
go back to reference Clark NM (2003) Management of chronic disease by patients. Annual Rev Public Health 24(1):289–313CrossRef Clark NM (2003) Management of chronic disease by patients. Annual Rev Public Health 24(1):289–313CrossRef
5.
go back to reference Fisher EB, Brownson CA, O’Toole ML, Shetty G, Anwuri VV, Glasgow RE (2005) Ecological approaches to self-management: the case of diabetes. Am J Public Health 95(9):1523–1535PubMedCrossRef Fisher EB, Brownson CA, O’Toole ML, Shetty G, Anwuri VV, Glasgow RE (2005) Ecological approaches to self-management: the case of diabetes. Am J Public Health 95(9):1523–1535PubMedCrossRef
6.
go back to reference Harrold LR, Andrade SE (2009) Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 38(5):396–402PubMedCrossRef Harrold LR, Andrade SE (2009) Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 38(5):396–402PubMedCrossRef
7.
go back to reference Salt E, Frazier S (2010) Adherence to disease modifying anti-rheumatic drugs in rheumatoid arthritis patients: a narrative review of the literature. Orthop Nurs 29(4):260–75PubMedCrossRef Salt E, Frazier S (2010) Adherence to disease modifying anti-rheumatic drugs in rheumatoid arthritis patients: a narrative review of the literature. Orthop Nurs 29(4):260–75PubMedCrossRef
8.
go back to reference Treharne GJ, Lyons AC, Kitas GD (2004) Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med 9(3):337–49CrossRef Treharne GJ, Lyons AC, Kitas GD (2004) Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med 9(3):337–49CrossRef
9.
go back to reference Park DC, Hertzog C, Leventhal H, Morrell RW, Leventhal E, Birchmore D (1999) Medication adherence in the elderly. J Am Geriatr Soc 47:172–83PubMed Park DC, Hertzog C, Leventhal H, Morrell RW, Leventhal E, Birchmore D (1999) Medication adherence in the elderly. J Am Geriatr Soc 47:172–83PubMed
10.
go back to reference Bradley LA (1989) Adherence with treatment regimens among adult rheumatoid arthritis patients: current status and future directions. Arthritis Rheum 2(3):S33–S39CrossRef Bradley LA (1989) Adherence with treatment regimens among adult rheumatoid arthritis patients: current status and future directions. Arthritis Rheum 2(3):S33–S39CrossRef
11.
go back to reference Kristensen LE, Saxne T, Nilsson J, Geborek P (2006) Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden. Arthritis Res Ther 8:R174PubMedCrossRef Kristensen LE, Saxne T, Nilsson J, Geborek P (2006) Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden. Arthritis Res Ther 8:R174PubMedCrossRef
13.
go back to reference Thorpe CT, DeVellis RF, Blalock SJ, Hogan SL, Lewis MA, DeVellis BM (2008) Patient perceptions about illness self-management in ANCA-associated small vessel vasculitis. Rheumatology 47(6):881–6PubMedCrossRef Thorpe CT, DeVellis RF, Blalock SJ, Hogan SL, Lewis MA, DeVellis BM (2008) Patient perceptions about illness self-management in ANCA-associated small vessel vasculitis. Rheumatology 47(6):881–6PubMedCrossRef
14.
go back to reference Pepper J, Carpenter D, DeVellis R (2012) Does adherence-related support from physicians and partners predict medication adherence for vasculitis patients? J Behav Med 35:115–23PubMedCrossRef Pepper J, Carpenter D, DeVellis R (2012) Does adherence-related support from physicians and partners predict medication adherence for vasculitis patients? J Behav Med 35:115–23PubMedCrossRef
15.
go back to reference Carpenter DM, DeVellis RF, Hogan SL, Fisher EB, DeVellis BM, Jordan JM (2010) The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Educ Couns 81(2):169–76PubMedCrossRef Carpenter DM, DeVellis RF, Hogan SL, Fisher EB, DeVellis BM, Jordan JM (2010) The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Educ Couns 81(2):169–76PubMedCrossRef
16.
go back to reference Popa-Lisseanu MG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM et al (2005) Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32:913–9 Popa-Lisseanu MG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM et al (2005) Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32:913–9
17.
go back to reference Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, Cox V, Kallen M, Janssen N et al (2008) Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27(7):883–9PubMedCrossRef Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, Cox V, Kallen M, Janssen N et al (2008) Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27(7):883–9PubMedCrossRef
18.
go back to reference Salt E, Peden A (2011) The complexity of the treatment: the decision-making process among women with rheumatoid arthritis. Qual Health Res 21(2):214–22PubMedCrossRef Salt E, Peden A (2011) The complexity of the treatment: the decision-making process among women with rheumatoid arthritis. Qual Health Res 21(2):214–22PubMedCrossRef
19.
go back to reference Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437–43PubMedCrossRef Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437–43PubMedCrossRef
20.
go back to reference Harrold LR, Andrade SE, Briesacher BA, Raebal MA, Fouayzi H, Yood RA et al (2009) Adherence with urate-lowering therapies of the treatment of gout. Arthritis Res Ther 11(2):R46PubMedCrossRef Harrold LR, Andrade SE, Briesacher BA, Raebal MA, Fouayzi H, Yood RA et al (2009) Adherence with urate-lowering therapies of the treatment of gout. Arthritis Res Ther 11(2):R46PubMedCrossRef
21.
go back to reference Jayne D (2005) How to induce remission in primary systemic vasculitis. Best Practice & Res Clin Rheumatol 19(2):293–305CrossRef Jayne D (2005) How to induce remission in primary systemic vasculitis. Best Practice & Res Clin Rheumatol 19(2):293–305CrossRef
22.
go back to reference Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
23.
go back to reference Thorpe CT, Devellis RF, Lewis MA, Blalock SJ, Hogan SL, Devellis BM (2007) Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Arthritis Care Res 57(7):1296–302CrossRef Thorpe CT, Devellis RF, Lewis MA, Blalock SJ, Hogan SL, Devellis BM (2007) Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Arthritis Care Res 57(7):1296–302CrossRef
24.
go back to reference Thorpe C (2006) Illness self-management among adults living with ANCA small vessel vasculitis. Dissertation, University of North Carolina at Chapel Hill. Thorpe C (2006) Illness self-management among adults living with ANCA small vessel vasculitis. Dissertation, University of North Carolina at Chapel Hill.
25.
go back to reference Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al (1994) Birmingham Vasculitis Activity Score (BVAS) Dim system necrotizinig vasculitis. QJM 87(11):671–8PubMed Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al (1994) Birmingham Vasculitis Activity Score (BVAS) Dim system necrotizinig vasculitis. QJM 87(11):671–8PubMed
26.
go back to reference DiMatteo MR, Haskard KB, Williams SL (2007) Health beliefs, disease severity, and patient adherence. Med Care 45(6):521–8PubMedCrossRef DiMatteo MR, Haskard KB, Williams SL (2007) Health beliefs, disease severity, and patient adherence. Med Care 45(6):521–8PubMedCrossRef
27.
go back to reference Dunbar-Jacob J, Mortimer-Stephens MK (2001) Treatment adherence in chronic disease. J Clinical Epidemiol 54(12):S57–S60CrossRef Dunbar-Jacob J, Mortimer-Stephens MK (2001) Treatment adherence in chronic disease. J Clinical Epidemiol 54(12):S57–S60CrossRef
28.
go back to reference Hajj-Ali RA, Wilke WS, Calabrese LH, Hoffman GS, Liu X, Bena J et al (2011) Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 63(6):827–33CrossRef Hajj-Ali RA, Wilke WS, Calabrese LH, Hoffman GS, Liu X, Bena J et al (2011) Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 63(6):827–33CrossRef
29.
go back to reference Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K (1998) Wegener’s granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 41(12):2257–62PubMedCrossRef Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K (1998) Wegener’s granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 41(12):2257–62PubMedCrossRef
30.
go back to reference Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW (2002) Patients’ perceptions of the effects of systemic lupus erythmatosus on health, function, income, and interpersonal relationships: a comparison with Wegener’s granulomatosis. Arthritis Rheum 47(2):196–201PubMedCrossRef Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW (2002) Patients’ perceptions of the effects of systemic lupus erythmatosus on health, function, income, and interpersonal relationships: a comparison with Wegener’s granulomatosis. Arthritis Rheum 47(2):196–201PubMedCrossRef
31.
go back to reference DiMatteo MR (2004) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 23(2):207–18PubMedCrossRef DiMatteo MR (2004) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 23(2):207–18PubMedCrossRef
32.
go back to reference Carpenter DM, DeVellis RF, Hogan SL, Fisher EB, DeVellis BM, Jordan JM (2011) Use and perceived credibility of medication information sources for vasculitis patients: differences by gender. J Health Comm 16(6):629–42CrossRef Carpenter DM, DeVellis RF, Hogan SL, Fisher EB, DeVellis BM, Jordan JM (2011) Use and perceived credibility of medication information sources for vasculitis patients: differences by gender. J Health Comm 16(6):629–42CrossRef
33.
go back to reference Carpenter DM, Meador AE, Elstad EA, Hogan SL, DeVellis RF (2012) The impact of vasculitis on patient social participation and friendships. Clin Exp Rheumatol 30:S15–S21PubMed Carpenter DM, Meador AE, Elstad EA, Hogan SL, DeVellis RF (2012) The impact of vasculitis on patient social participation and friendships. Clin Exp Rheumatol 30:S15–S21PubMed
34.
go back to reference Treharne GJ, Lyons AC, Hale ED, Douglas KMJ, Kitas GD (2006) 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology 45(1):1–5PubMedCrossRef Treharne GJ, Lyons AC, Hale ED, Douglas KMJ, Kitas GD (2006) 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology 45(1):1–5PubMedCrossRef
Metadata
Title
Predictors of medication non-adherence for vasculitis patients
Authors
Delesha M. Carpenter
Susan L. Hogan
Robert F. DeVellis
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2164-z

Other articles of this Issue 5/2013

Clinical Rheumatology 5/2013 Go to the issue